Cargando…

SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma

When patients with chronic kidney disease are infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) they can face two specific problems: virus‐specific immune responses may be impaired and remdesivir, an antiviral drug described to shorten recovery, is contraindicated. Antiviral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindemann, Monika, Krawczyk, Adalbert, Dolff, Sebastian, Konik, Margarethe, Rohn, Hana, Platte, Maximillian, Thümmler, Laura, Schwarzkopf, Sina, Schipper, Leonie, Bormann, Maren, van de Sand, Lukas, Breyer, Marianne, Klump, Hannes, Knop, Dietmar, Lenz, Veronika, Temme, Christian, Dittmer, Ulf, Horn, Peter A., Witzke, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014298/ https://www.ncbi.nlm.nih.gov/pubmed/33527424 http://dx.doi.org/10.1002/jmv.26840

Ejemplares similares

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
por: Schwarzkopf, Sina, et al.
Publicado: (2021)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age
por: Konik, Margarethe, et al.
Publicado: (2021)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes
por: Bormann, Maren, et al.
Publicado: (2021)

Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
por: Thümmler, Laura, et al.
Publicado: (2022)

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
por: van de Sand, Lukas, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study
por: Korth, Johannes, et al.
Publicado: (2021)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses
por: van de Sand, Lukas, et al.
Publicado: (2021)

COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital
por: Wünsch, Korbinian, et al.
Publicado: (2022)

The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
por: Möhlendick, Birte, et al.
Publicado: (2022)

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients
por: Thümmler, Laura, et al.
Publicado: (2022)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

COVID-19 associated acute transplant failure after AB0-incompatible living donor kidney transplantation – a case report
por: Boss, Kristina, et al.
Publicado: (2023)

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
por: Korth, Johannes, et al.
Publicado: (2020)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro
por: Bormann, Maren, et al.
Publicado: (2021)

Susceptibility of SARS-CoV-2 to UV irradiation
por: Heilingloh, Christiane Silke, et al.
Publicado: (2020)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
por: Thümmler, Laura, et al.
Publicado: (2021)

Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study
por: Alt, Mira, et al.
Publicado: (2023)

A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19
por: Reinold, Johanna, et al.
Publicado: (2021)

The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients
por: Reinold, Johanna, et al.
Publicado: (2022)

False-Positive Screening and Confirmatory HIV Diagnostic Test in a Patient with Cured SARS-CoV-2 Infection Is Not Mediated by Env/Spike Cross-Reactive Antibodies
por: Elsner, Carina, et al.
Publicado: (2023)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2022)

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients
por: Mülling, Nils, et al.
Publicado: (2023)

Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2021)

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients
por: van de Sand, Lukas, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Fear of Death during COVID-19 Does Not Explain Post-Infection Depression Symptoms beyond Reported Symptoms during the Infection in COVID-19 Survivors
por: Speichert, Leoni-Johanna, et al.
Publicado: (2022)

Chloroquine Suppresses Effector B-Cell Functions and Has Differential Impact on Regulatory B-Cell Subsets
por: Ma, Xin, et al.
Publicado: (2022)

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants
por: Gäckler, Anja, et al.
Publicado: (2019)

Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNA
por: Wolff, Natalie, et al.
Publicado: (2022)

Wellenreiten – 12 Monate COVID-19 im Maximalversorger
por: Fistera, David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h48friifs6fe5l8dtv7h027ral